Singapore markets closed

BioCryst Pharmaceuticals, Inc. (BCRX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
10.52-0.03 (-0.28%)
At close: 04:00PM EST
11.02 +0.50 (+4.75%)
Pre-market: 08:00AM EST
Currency in USD
Earnings estimateCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
No. of analysts1151212
Avg. Estimate-0.17-0.24-1.11-0.87
Low estimate-0.45-0.49-1.39-1.79
High estimate0.16-0.11-0.82-0.47
Year ago EPS-0.1-0.4-1.03-1.11
Revenue estimateCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
No. of analysts1041111
Avg. Estimate75.98M75.62M267.19M348.43M
Low estimate71.1M71.3M261.5M294M
High estimate88.1M83.32M281M382.8M
Year ago sales47.16M49.92M157.17M267.19M
Sales growth (year/est)61.10%51.50%70.00%30.40%
Earnings history30/12/202130/03/202229/06/202229/09/2022
Est. EPS-0.3-0.37-0.34-0.29
Actual EPS-0.1-0.4-0.32-0.23
Difference0.2-0.030.020.06
Surprise %66.70%-8.10%5.90%20.70%
EPS trendCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
Current estimate-0.17-0.24-1.11-0.87
7 days ago-0.17-0.24-1.11-0.87
30 days ago-0.16-0.27-1.11-0.79
60 days ago-0.16-0.35-1.11-0.8
90 days ago-0.16-0.33-1.14-0.84
EPS revisionsCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
Up last 7 daysN/AN/AN/A1
Up last 30 daysN/AN/AN/A1
Down last 7 daysN/AN/AN/AN/A
Down last 30 days212N/A
Growth estimatesBCRXIndustrySector(s)S&P 500
Current qtr.-70.00%N/AN/AN/A
Next qtr.40.00%N/AN/AN/A
Current year-7.80%N/AN/AN/A
Next year21.60%N/AN/AN/A
Next 5 years (per annum)15.20%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A